FDA FDA releases new strategic framework for assessing the potential use of RWE in connection with drug review program Click here to find out more   ASH Researchers Identify Mutation in BCL2 Protein That Causes Resistance to Venetoclax in Progressive CLL2 Click here to find out more   NICE NICE recommends MSD’s Keytruda within the CDF […]